• 8th April 2020

    NICE pauses appraisals of all CGRP drug treatments due to coronavirus (Covid-19)

    NICE says it’s unable to say when this or other paused appraisals will resume

    Read more
  • 18th March 2020

    The Migraine Trust is here to help you

    A personal message from The Migraine Trust Chief Executive about coronavirus (Covid-19)

    Read more
  • 12th March 2020

    NICE gives chronic migraine patients access to ‘life changing’ new drug

    Fremanezumab (Ajovy) has been approved for use within the NHS in England and Wales

    Read more
  • 28th February 2020

    We have launched our new five-year strategy

    We are proud that our new strategy closely reflects what people affected by migraine have told us they most want and need from our charity

    Read more
  • 20th February 2020

    Launching our new Migraine Trust Ambassador Programme

    We would like to find two more people to be ambassadors this year

    Read more